Shares of Celldex Therapeutics shot up after a team of top researchers achieved prominent attention for some impressive mid-stage clinical trial results for a new therapeutic vaccine designed to fight brain cancer.
The scientists from Duke...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Celldex Therapeutic (BER:TCE1):